Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1986 Oct;78(4):1072–1082. doi: 10.1172/JCI112663

Role of shear rate and platelets in promoting fibrin formation on rabbit subendothelium. Studies utilizing patients with quantitative and qualitative platelet defects.

H J Weiss, V T Turitto, H R Baumgartner
PMCID: PMC423764  PMID: 3760183

Abstract

The deposition of platelets on subendothelium of rabbit aortic segments exposed to non-anticoagulated human blood increased progressively with increasing wall shear rates (50-2,600 s-1), whereas fibrin deposition decreased. Studies in normal subjects and patients with platelet disorders suggested that, under the conditions used, platelets were essential for fibrin deposition at intermediate (650 s-1) but not low (50 s-1) shear rates. Fibrin deposition was markedly diminished in a patient with Scott syndrome whose platelets have a diminished capacity to bind Factor Xa and activate Factors IX and II. In glycoprotein IIb-IIIa deficiency, fibrin deposition was normal (or somewhat increased), whereas in glycoprotein Ib deficiency the association of fibrin with platelets, but not subendothelium, was decreased. The findings indicate that platelets, perhaps through surface localization of coagulation proteins, promote fibrin deposition on subendothelium at arterial shear rates and suggest that agents directed against platelet coagulant properties could be antithrombotic.

Full text

PDF
1072

Images in this article

1077Image
on p.1077

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adelman B., Stemerman M. B., Handin R. I. Interaction of platelets and fibrin with injured rabbit aortic neointima. Effect of prostaglandin I2 and heparin. Arteriosclerosis. 1983 Mar-Apr;3(2):141–148. doi: 10.1161/01.atv.3.2.141. [DOI] [PubMed] [Google Scholar]
  2. BERNARD J., CAEN J., MAROTEAU P. La dystrophie thrombocytaire hémorragipare congénitale. Rev Hematol. 1957 Apr-Jun;12(2):222–249. [PubMed] [Google Scholar]
  3. Baumgartner H. R. Effects of anticoagulation on the interaction of human platelets with subendothelium in flowing blood. Schweiz Med Wochenschr. 1976 Oct 2;106(40):1367–1368. [PubMed] [Google Scholar]
  4. Baumgartner H. R. The role of blood flow in platelet adhesion, fibrin deposition, and formation of mural thrombi. Microvasc Res. 1973 Mar;5(2):167–179. doi: 10.1016/0026-2862(73)90069-1. [DOI] [PubMed] [Google Scholar]
  5. Baumgartner H. R., Turitto V., Weiss H. J. Effect of shear rate on platelet interaction with subendothelium in citrated and native blood. II. Relationships among platelet adhesion, thrombus dimensions, and fibrin formation. J Lab Clin Med. 1980 Feb;95(2):208–221. [PubMed] [Google Scholar]
  6. Berndt M. C., Phillips D. R. Purification and preliminary physicochemical characterization of human platelet membrane glycoprotein V. J Biol Chem. 1981 Jan 10;256(1):59–65. [PubMed] [Google Scholar]
  7. CHAPMAN I. MORPHOGENESIS OF OCCLUDING CORONARY ARTERY THROMBOSIS. Arch Pathol. 1965 Sep;80:256–261. [PubMed] [Google Scholar]
  8. Caen J., Bellucci S. The defective prothrombin consumption in Bernard-Soulier syndrome. Hypotheses from 1948 to 1982. Blood Cells. 1983;9(2):389–399. [PubMed] [Google Scholar]
  9. Castaldi P. A., Larrieu M. J., Caen J. Availability of platelet Factor 3 and activation of factor XII in thrombasthenia. Nature. 1965 Jul 24;207(995):422–424. doi: 10.1038/207422a0. [DOI] [PubMed] [Google Scholar]
  10. Clemetson K. J., McGregor J. L., James E., Dechavanne M., Lüscher E. F. Characterization of the platelet membrane glycoprotein abnormalities in Bernard-Soulier syndrome and comparison with normal by surface-labeling techniques and high-resolution two-dimensional gel electrophoresis. J Clin Invest. 1982 Aug;70(2):304–311. doi: 10.1172/JCI110618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Deykin D. Thrombogenesis. N Engl J Med. 1967 Mar 16;276(11):622–628. doi: 10.1056/NEJM196703162761107. [DOI] [PubMed] [Google Scholar]
  12. George J. N., Nurden A. T., Phillips D. R. Molecular defects in interactions of platelets with the vessel wall. N Engl J Med. 1984 Oct 25;311(17):1084–1098. doi: 10.1056/NEJM198410253111705. [DOI] [PubMed] [Google Scholar]
  13. Goldsmith H. L. The flow of model particles and blood cells and its relation to thrombogenesis. Prog Hemost Thromb. 1972;1:97–127. [PubMed] [Google Scholar]
  14. Groves H. M., Kinlough-Rathbone R. L., Richardson M., Jørgensen L., Moore S., Mustard J. F. Thrombin generation and fibrin formation following injury to rabbit neointima. Studies of vessel wall reactivity and platelet survival. Lab Invest. 1982 Jun;46(6):605–612. [PubMed] [Google Scholar]
  15. Groves H. M., Kinlough-Rathbone R. L., Richardson M., Moore S., Mustard J. F. Platelet interaction with damaged rabbit aorta. Lab Invest. 1979 Feb;40(2):194–200. [PubMed] [Google Scholar]
  16. Haeberli A., Straub P. W. Quantitative determination of fibrin and fibrinogen in biological material. J Lab Clin Med. 1980 Aug;96(2):258–266. [PubMed] [Google Scholar]
  17. Hemker H. C., van Rijn J. L., Rosing J., van Dieijen G., Bevers E. M., Zwaal R. F. Platelet membrane involvement in blood coagulation. Blood Cells. 1983;9(2):303–317. [PubMed] [Google Scholar]
  18. Jamieson G. A., Okumura T., Fishback B., Johnson M. M., Egan J. J., Weiss H. J. Platelet membrane glycoproteins in thrombasthenia, Bernard-Soulier syndrome, and storage pool disease. J Lab Clin Med. 1979 Apr;93(4):652–660. [PubMed] [Google Scholar]
  19. Jamieson G. A., Okumura T. Reduced thrombin binding and aggregation in Bernard-Soulier platelets. J Clin Invest. 1978 Mar;61(3):861–864. doi: 10.1172/JCI109000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Jorgensen L., Packham M. A., Rowsell H. C., Mustard J. F. Deposition of formed elements of blood on the intima and signs of intimal injury in the aorta of rabbit, pig, and man. Lab Invest. 1972 Sep;27(3):341–350. [PubMed] [Google Scholar]
  21. Kane W. H., Lindhout M. J., Jackson C. M., Majerus P. W. Factor Va-dependent binding of factor Xa to human platelets. J Biol Chem. 1980 Feb 10;255(3):1170–1174. [PubMed] [Google Scholar]
  22. Kane W. H., Majerus P. W. The interaction of human coagulation factor Va with platelets. J Biol Chem. 1982 Apr 10;257(7):3963–3969. [PubMed] [Google Scholar]
  23. Kaplan K. L., Drillings M., Lesznik G. Fibrinopeptide A cleavage and platelet release in whole blood in vitro. Effects of stimuli, inhibitors, and agitation. J Clin Invest. 1981 May;67(5):1561–1568. doi: 10.1172/JCI110187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kornecki E., Niewiarowski S., Morinelli T. A., Kloczewiak M. Effects of chymotrypsin and adenosine diphosphate on the exposure of fibrinogen receptors on normal human and Glanzmann's thrombasthenic platelets. J Biol Chem. 1981 Jun 10;256(11):5696–5701. [PubMed] [Google Scholar]
  25. Laffel G. L., Braunwald E. Thrombolytic therapy. A new strategy for the treatment of acute myocardial infarction (1). N Engl J Med. 1984 Sep 13;311(11):710–717. doi: 10.1056/NEJM198409133111105. [DOI] [PubMed] [Google Scholar]
  26. Majerus P. W., Miletich J. P. Relationships between platelets and coagulation factors in hemostasis. Annu Rev Med. 1978;29:41–49. doi: 10.1146/annurev.me.29.020178.000353. [DOI] [PubMed] [Google Scholar]
  27. Marlar R. A., Kleiss A. J., Griffin J. H. An alternative extrinsic pathway of human blood coagulation. Blood. 1982 Dec;60(6):1353–1358. [PubMed] [Google Scholar]
  28. McGowan E. B., Ding A., Detwiler T. C. Correlation of thrombin-induced glycoprotein V hydrolysis and platelet activation. J Biol Chem. 1983 Sep 25;258(18):11243–11248. [PubMed] [Google Scholar]
  29. Miletich J. P., Jackson C. M., Majerus P. W. Properties of the factor Xa binding site on human platelets. J Biol Chem. 1978 Oct 10;253(19):6908–6916. [PubMed] [Google Scholar]
  30. Miletich J. P., Kane W. H., Hofmann S. L., Stanford N., Majerus P. W. Deficiency of factor Xa-factor Va binding sites on the platelets of a patient with a bleeding disorder. Blood. 1979 Nov;54(5):1015–1022. [PubMed] [Google Scholar]
  31. Niewiarowski S., Levy-Toledano S., Caen J. P. Platelet interaction with polymerizing fibrin in Glanzmann's thrombasthenia. 1981 Aug 15-Sep 1Thromb Res. 23(4-5):457–463. doi: 10.1016/0049-3848(81)90207-3. [DOI] [PubMed] [Google Scholar]
  32. Nossel H. L., Yudelman I., Canfield R. E., Butler V. P., Jr, Spanondis K., Wilner G. D., Qureshi G. D. Measurement of fibrinopeptide A in human blood. J Clin Invest. 1974 Jul;54(1):43–53. doi: 10.1172/JCI107749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Nurden A. T., Didry D., Rosa J. P. Molecular defects of platelets in Bernard-Soulier syndrome. Blood Cells. 1983;9(2):333–358. [PubMed] [Google Scholar]
  34. Osterud B., Rapaport S. I. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5260–5264. doi: 10.1073/pnas.74.12.5260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Rosing J., Bevers E. M., Comfurius P., Hemker H. C., van Dieijen G., Weiss H. J., Zwaal R. F. Impaired factor X and prothrombin activation associated with decreased phospholipid exposure in platelets from a patient with a bleeding disorder. Blood. 1985 Jun;65(6):1557–1561. [PubMed] [Google Scholar]
  36. Rosing J., van Rijn J. L., Bevers E. M., van Dieijen G., Comfurius P., Zwaal R. F. The role of activated human platelets in prothrombin and factor X activation. Blood. 1985 Feb;65(2):319–332. [PubMed] [Google Scholar]
  37. Sevitt S. The structure and growth of valve-pocket thrombi in femoral veins. J Clin Pathol. 1974 Jul;27(7):517–528. doi: 10.1136/jcp.27.7.517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Sixma J. J., Wester J. The hemostatic plug. Semin Hematol. 1977 Jul;14(3):265–299. [PubMed] [Google Scholar]
  39. Stemerman M. B., Baumgartner H. R., Spaet T. H. The subendothelial microfibril and platelet adhesion. Lab Invest. 1971 Mar;24(3):179–186. [PubMed] [Google Scholar]
  40. Stemerman M. B. Thrombogenesis of the rabbit arterial plaque. An electron microscopic study. Am J Pathol. 1973 Oct;73(1):7–26. [PMC free article] [PubMed] [Google Scholar]
  41. Tracy P. B., Nesheim M. E., Mann K. G. Coordinate binding of factor Va and factor Xa to the unstimulated platelet. J Biol Chem. 1981 Jan 25;256(2):743–751. [PubMed] [Google Scholar]
  42. Tschopp T. B., Weiss H. J., Baumgartner H. R. Decreased adhesion of platelets to subendothelium in von Willebrand's disease. J Lab Clin Med. 1974 Feb;83(2):296–300. [PubMed] [Google Scholar]
  43. Turitto V. T., Baumgartner H. R. Platelet interaction with subendothelium in flowing rabbit blood: effect of blood shear rate. Microvasc Res. 1979 Jan;17(1):38–54. doi: 10.1016/0026-2862(79)90006-2. [DOI] [PubMed] [Google Scholar]
  44. Turitto V. T., Weiss H. J., Baumgartner H. R. Platelet interaction with rabbit subendothelium in von Willebrand's disease: altered thrombus formation distinct from defective platelet adhesion. J Clin Invest. 1984 Nov;74(5):1730–1741. doi: 10.1172/JCI111591. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Walsh P. N., Biggs R. The role of platelets in intrinsic factor-Xa formation. Br J Haematol. 1972 Jun;22(6):743–760. doi: 10.1111/j.1365-2141.1972.tb05719.x. [DOI] [PubMed] [Google Scholar]
  46. Walsh P. N., Mills D. C., Pareti F. I., Stewart G. J., Macfarlane D. E., Johnson M. M., Egan J. J. Hereditary giant platelet syndrome. Absence of collagen-induced coagulant activity and deficiency of factor-XI binding to platelets. Br J Haematol. 1975 Apr;29(4):639–655. doi: 10.1111/j.1365-2141.1975.tb02750.x. [DOI] [PubMed] [Google Scholar]
  47. Walsh P. N. Platelet coagulant activities and hemostasis: a hypothesis. Blood. 1974 Apr;43(4):597–605. [PubMed] [Google Scholar]
  48. Walsh P. N. Platelet coagulant activities in thrombasthenia. Br J Haematol. 1972 Nov;23(5):553–569. doi: 10.1111/j.1365-2141.1972.tb07091.x. [DOI] [PubMed] [Google Scholar]
  49. Weiss H. J., Kochwa S. Studies of platelet function and proteins in 3 patients with Glanzmann's thrombasthenia. J Lab Clin Med. 1968 Jan;71(1):153–165. [PubMed] [Google Scholar]
  50. Weiss H. J., Kochwa S. Studies of platelet function and proteins in 3 patients with Glanzmann's thrombasthenia. J Lab Clin Med. 1968 Jan;71(1):153–165. [PubMed] [Google Scholar]
  51. Weiss H. J. Platelet physiology and abnormalities of platelet function (second of two parts). N Engl J Med. 1975 Sep 18;293(12):580–588. doi: 10.1056/NEJM197509182931204. [DOI] [PubMed] [Google Scholar]
  52. Weiss H. J., Tschopp T. B., Baumgartner H. R., Sussman I. I., Johnson M. M., Egan J. J. Decreased adhesion of giant (Bernard-Soulier) platelets to subendothelium. Further implications on the role of the von Willebrand factor in hemostasis. Am J Med. 1974 Dec;57(6):920–925. doi: 10.1016/0002-9343(74)90170-3. [DOI] [PubMed] [Google Scholar]
  53. Weiss H. J., Turitto V. T., Baumgartner H. R. Effect of shear rate on platelet interaction with subendothelium in citrated and native blood. I. Shear rate--dependent decrease of adhesion in von Willebrand's disease and the Bernard-Soulier syndrome. J Lab Clin Med. 1978 Nov;92(5):750–764. [PubMed] [Google Scholar]
  54. Weiss H. J., Turitto V. T., Baumgartner H. R. Platelet adhesion and thrombus formation on subendothelium in platelets deficient in glycoproteins IIb-IIIa, Ib, and storage granules. Blood. 1986 Feb;67(2):322–330. [PubMed] [Google Scholar]
  55. Weiss H. J., Turitto V. T., Vicic W. J., Baumgartner H. R. Fibrin formation, fibrinopeptide A release, and platelet thrombus dimensions on subendothelium exposed to flowing native blood: greater in factor XII and XI than in factor VIII and IX deficiency. Blood. 1984 May;63(5):1004–1014. [PubMed] [Google Scholar]
  56. Weiss H. J., Vicic W. J., Lages B. A., Rogers J. Isolated deficiency of platelet procoagulant activity. Am J Med. 1979 Aug;67(2):206–213. doi: 10.1016/0002-9343(79)90392-9. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES